4.6 Article

Barriers to HIV Testing in Cote d'Ivoire: The Role of Individual Characteristics and Testing Modalities

Journal

PLOS ONE
Volume 7, Issue 7, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0041353

Keywords

-

Funding

  1. EHESP (Ecole des Hautes Etudes en Sante Publique)-School of Public Heath, Rennes, France

Ask authors/readers for more resources

Background: Expanding HIV testing requires a better understanding of barriers to its uptake. We investigated barriers to HIV testing in Cote d'Ivoire, taking into account test circumstances (client vs. provider-initiated). Methods: We used data from the 2005 nationally representative Demographic and Health Survey conducted in Cote d'Ivoire. Socio-demographic characteristics, sexual behaviour and knowledge and attitudes toward HIV/AIDS associated with recent (<2 years) HIV testing were identified using gender-specific univariate and multivariate logistic regressions. Among women, differential effects of barriers to testing according to test circumstance (whether they have been offered for a prenatal test or not) were assessed through interaction tests. Results: Recent HIV testing was reported by 6.1% of men and 9.5% of women (including 4.6% as part of antenatal care). Among men, having a low socioeconomic status, having a low HIV-related knowledge level and being employed [ compared to those inactive: adjusted Odds Ratio (aOR) 0.46; 95% confidence interval (CI) 0.25-0.87] were associated with lower proportions of recent HIV testing. Among women without a prenatal HIV testing offer, living outside the capital (aOR 0.38; CI 0.19-0.77) and reporting a unique lifetime sexual partner constituted additional barriers to HIV testing. By contrast, among women recently offered to be tested in prenatal care, none of these variables was found to be associated with recent HIV testing. Conclusions: Various dimensions of individuals' characteristics constituted significant barriers to HIV testing in Cote d'Ivoire in 2005, with gender specificities. Such barriers are substantially reduced when testing was proposed in the framework of antenatal care. This suggests that provider-initiated testing strategies may help overcome individual barriers to HIV testing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Hematology

Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories-A French population-based study using the French national health data system

Clementine Vabre, Yoann Zelmat, Martin Gauthier, Marie Pajiep, Cecile Conte, Maryse Lapeyre-Mestre, Rosemary Dray-Spira, Mahmoud Zureik, Fabien Despas

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Review Medicine, General & Internal

Pediatric Outpatient Prescriptions in Countries With Advanced Economies in the 21st Century A Systematic Review

Marion Taine, Lucile Offredo, Alain Weill, Rosemary Dray-Spira, Mahmoud Zureik, Martin Chalumeau

Summary: This study found significant variations in pediatric outpatient prescriptions (POPs) between different countries, indicating the presence of inappropriate prescriptions. These findings may guide educational campaigns and regulatory decisions in some OECD member countries.

JAMA NETWORK OPEN (2022)

Article Gastroenterology & Hepatology

Maternal Exposure to Anti-TNF or Thiopurines for IBD Does Not Increase Risk of Early-life Malignancy in Children

Antoine Meyer, Paula Rios, Jerome Drouin, Alain Weill, Franck Carbonnel, Rosemary Dray-spira

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Obstetrics & Gynecology

Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population-based study

Noemie Roland, Berangere Baricault, Rosemary Dray-Spira, Alain Weill, Lise Duranteau, Mahmoud Zureik

Summary: This study assessed the user profiles and continuation rates of Cu-IUDs and LNG-IUSs in France in 2019. The findings indicate that LNG-IUS use is associated with being aged 35-44, receiving a prescription from a gynecologist, and having a gynecological history. Cu-IUDs have a higher continuation rate compared to LNG-IUSs.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2023)

Article Pharmacology & Pharmacy

Trends in anti-infective use during pregnancy in France between 2010 and 2019: a nationwide population-based study

Sarah Tubiana, Jeanne Sibiude, Philippe Herlemont, Jerome Drouin, Olivier Picone, Xavier Duval, Alain Weill, Mahmoud Zureik, Rosemary Dray-Spira

Summary: This study investigated the trends in anti-infective use during pregnancy from 2010 to 2019 using the French national health data system. The study found a decrease in the use of antibacterials and an increase in the use of antiviral agents. The study also suggested room for improvement in influenza vaccination.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Letter Medicine, General & Internal

Association Between Doses of Levonorgestrel Intrauterine Systems and Subsequent Use of Psychotropic Drugs in France

Noemie Roland, Berangere Baricault, Alain Weill, Kim Bouillon, Rosemary Dray-Spira, Lise Duranteau, Mahmoud Zureik

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Rheumatology

Prevalence, mortality, and treatment of patients with rheumatoid arthritis: A cohort study of the French National Health Data System, 2010-2019

Laura Pina Vegas, Jerome Drouin, Rosemary Dray-Spira, Alain Weill

Summary: This study aimed to estimate the prevalence and mortality rate of rheumatoid arthritis (RA) in France and characterize the causes of death and prescribed treatments. The results showed a relatively low prevalence but higher mortality rate of RA in France, with increased mortality in cardiovascular, respiratory, digestive, urogenital diseases, and infections. Some patients were treated with conventional synthetic and biological/targeted synthetic disease-modifying antirheumatic drugs for RA.

JOINT BONE SPINE (2023)

Article Pharmacology & Pharmacy

Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines

Mahmoud Zureik, Francois Cuenot, Alain Weill, Rosemary Dray-Spira

Summary: The French scientific group EPI-PHARE has reoriented its work to provide valuable insights to health authorities during the COVID-19 pandemic. By analyzing extensive data from the French Health Data System, EPI-PHARE has published numerous results on the use, benefits, and risks of medicines, as well as the risk factors associated with COVID-19 and the efficacy and risks of COVID-19 vaccines. These findings have played a significant role in informing decision-making and ensuring public health in France.

THERAPIE (2023)

Article Pharmacology & Pharmacy

Impact of coronavirus disease 2019 on contraception use in France

Noemie Roland, Jerome Drouin, David Desplas, Lise Duranteau, Francois Cuenot, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik

Summary: This study assessed the impact of the COVID 19 pandemic on reimbursed contraceptives in France. After 15 months of the pandemic, a decrease in the dispensation of all reimbursed contraceptives was observed, with the greatest impact on women under 25 years old. These results highlight the need for long-term monitoring of contraceptive use and prioritizing access to sexual health services, especially for young women.

THERAPIE (2023)

Article Oncology

Changes in Presentation, Treatment, and Survival of Patients with Hepatocellular Carcinoma in Damietta, Egypt, 2007-2019: A Retrospective Monocentric Cohort Study

Kevin Jean, Ahmed Tawheed, Liem Binh Luong Nguyen, Tarek Heikal, Usama Eldaly, Neveen Elhadidy, Ahmed Elghaieb, Ahmed Aboudonia, Laura Tondeur, Amelie Dublineau, Arnaud Fontanet, Mohamed El-Kassas

Summary: This study aimed to assess temporal changes in the presentation and survival of patients with hepatocellular carcinoma (HCC) in northern Egypt, one of the regions with the highest incidence of the disease globally. The study found that although there was an increasing trend in early diagnosis of HCC, there was no significant improvement in overall survival over time.

JOURNAL OF HEPATOCELLULAR CARCINOMA (2023)

Letter Medicine, General & Internal

Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster

Marie-Joelle Jabagi, Marion Bertrand, Jeremie Botton, Stephane Le Vu, Alain Weill, Rosemary Dray-Spira, Mahmoud Zureik

Summary: In this French study, recipients of the bivalent vaccine and the original monovalent vaccine had similar risk of cardiovascular events 21 days after vaccination.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Pharmacology & Pharmacy

Roll-out and effectiveness of HIV pre-exposure prophylaxis in France: An overview

Sophie Billioti de Gage, Hugo Jourdain, David Desplas, Rosemary Dray-Spira

Summary: This article evaluates the roll-out and real-life effectiveness of oral HIV pre-exposure prophylaxis (PrEP) in France. The findings show that PrEP initiation increased steadily, but was significantly impacted by the COVID-19 pandemic. The majority of PrEP users were men living in urban areas. Adherence to PrEP was generally high, but a substantial proportion of early treatment discontinuation was observed. Overall PrEP effectiveness was 60%, but varied among different population groups.

THERAPIE (2023)

Article Immunology

Spatio-temporal changes in pre-exposure prophylaxis uptake among MSM in mainland France between 2016 and 2021: a Bayesian small area approach with MSM population estimation

Haoyi Wang, Jean-Michel Molina, Rosemary Dray-Spira, Axel J. Schmidt, Ford Hickson, David van de Vijver, Kai J. Jonas

Summary: This study used national pharmaco-epidemiology surveillance data and regional MSM population estimations to model the spatio-temporal distribution of PrEP uptake among MSM in France 2016-2021 to identify marginalized MSM at risk for HIV and increase their PrEP uptake.

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2023)

Article Multidisciplinary Sciences

Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study

Moussa Laanani, Alain Weill, Fabrice Jollant, Mahmoud Zureik, Rosemary Dray-Spira

Summary: A nationwide cohort study in France found that finasteride, a 5 alpha-reductase inhibitor used in the treatment of benign prostatic hyperplasia, may be associated with an increased risk of suicide, particularly among individuals with a history of mood disorders.

SCIENTIFIC REPORTS (2023)

No Data Available